Anti-myelin oligodendrocyte glycoprotein antibodies in a patient with recurrent optic neuritis involving the cerebral white matter and brainstem

Internal Medicine

Volumn 55, Issue 10, 2016, Pages 1351-1354

  Adachi, Tadashi ^a   Yasui, Kenichi ^a   Takahashi, Toshiyuki ^b,c   Fujihara, Kazuo ^c   Watanabe, Yasuhiro ^a   Nakashima, Kenji ^a  

^a TOTTORI UNIVERSITY   (Japan)

^b Yonezawa National Hospital   (Japan)

^c TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Brainstem; MOG; MRI; NMO; White matter

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN G; METHYLPREDNISOLONE; OLIGODENDROCYTE MYELIN GLYCOPROTEIN ANTIBODY; PREDNISOLONE; PROTEIN; UNCLASSIFIED DRUG; MYELIN OLIGODENDROCYTE GLYCOPROTEIN;

ADULT; ARTICLE; BLINDNESS; BRAIN STEM; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DRUG DOSE REDUCTION; DRUG PULSE THERAPY; ELECTROENCEPHALOGRAPHY; EVOKED BRAIN STEM AUDITORY RESPONSE; EYE MOVEMENT; EYE PAIN; FEMALE; HOSPITAL ADMISSION; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NEURITIS; PREGNANCY; URINALYSIS; VISUAL ACUITY; VISUAL EVOKED POTENTIAL; WHITE MATTER; YOUNG ADULT; CHRONIC DISEASE; IMMUNOLOGY; RECURRENT DISEASE;

BRAIN STEM; CHRONIC DISEASE; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; OPTIC NEURITIS; RECURRENCE; WHITE MATTER; YOUNG ADULT;

EID: 84968830745     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.55.6122     Document Type: Article

References (14)

1. Rostasy K, Reindl M. Role of autoantibodies in acquired inflammatory demyelinating diseases of the central nervous system in children. Neuropediatrics 44: 297-301, 2013.
2. Baumann M, Sahin K, Lechner C, et al. Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein. J Neurol Neurosurg Psychiatry 86: 265-272, 2015.
3. Kitley J, Woodhall M, Waters P, et al. Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype. Neurology 79: 1273-1277, 2012.
4. Kitley J, Waters P, Woodhall M, et al. Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study. JAMA Neurol 71: 276-283, 2014.
5. Sato DK, Callegaro D, Lana-Peixoto MA, et al. Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders. Neurology 82: 474-481, 2014.
6. Nakajima H, Motomura M, Tanaka K, et al. Antibodies to myelin oligodendrocyte glycoprotein in idiopathic optic neuritis. BMJ Open 5: e007766, 2015.
7. Sato DK, Nakashima I, Takahashi T, et al. Aquaporin-4 antibody-positive cases beyond current diagnostic criteria for NMO spectrum disorders. Neurology 80: 2210-2216, 2013.
8. Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG. The spectrum of neuromyelitis optica. Lancet Neurol 6: 805-815, 2007.
9. Amano H, Miyamoto N, Shimura H, et al. Influenza-associated MOG antibody-positive longitudinally extensive transverse myelitis: a case report. BMC Neurol 14: 224, 2014.
10. Brunner C, Lassmann H, Waehneldt TV, Matthieu JM, Linington C. Differential ultrastructural localization of myelin basic protein, myelin/oligodendroglial glycoprotein, and 2’,3’-cyclic nucleotide 3’-phosphodiesterase in the CNS of adult rats. J Neurochem 52: 296-304, 1989.
11. Reindl M, Di Pauli F, Rostasy K, Berger T. The spectrum of MOG autoantibody-associated demyelinating diseases. Nat Rev Neurol 9: 455-461, 2013.
12. Misu T, Sato DK, Nakashima I, Fujihara K. MOG-IgG serological status matters in paediatric ADEM. J Neurol Neurosurg Psychiatry 86: 242, 2015.
13. Kezuka T, Tanaka K, Matsunaga Y, Goto H. Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders. Neurology 83: 475, 2014.
14. Wingerchuk DM, Banwell B, Bennett JL, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85: 177-189, 2015.